Provided by Tiger Trade Technology Pte. Ltd.

Urogen Pharma Ltd.

41.40
+0.85002.10%
Post-market: 41.400.00000.00%19:30 EDT
Volume:604.96K
Turnover:24.87M
Market Cap:2.02B
PE:-21.02
High:41.82
Open:40.93
Low:40.05
Close:40.55
52wk High:50.81
52wk Low:15.86
Shares:48.68M
Float Shares:43.35M
Volume Ratio:0.81
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9700
EPS(LYR):-3.1901
ROE:-1481.26%
ROA:-18.06%
PB:-15.22
PE(LYR):-12.98

Loading ...

Sep 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2026

Major Issues Report

Form 8-K - Current report
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2026

Major Issues Report

Form 8-K - Current report
Apr 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 02, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2026

Major Issues Report

Form 8-K - Current report